Slowly phasing out mentions of sepsis for 'urosepsis'. We all know why, yet they refuse to acknowledge it and be upfront with shareholders.
This timeline is very confusing. Not sure how many individual trials are planned. But pretty sure the timeline will blowout.
.![]()
- Forums
- ASX - By Stock
- Ann: RCE Corporate Presentation at Ord Minnett Healthcare Forum
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.08%
!
31.5¢

Slowly phasing out mentions of sepsis for 'urosepsis'....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.5¢ |
Change
-0.010(3.08%) |
Mkt cap ! $90.83M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 30.5¢ | $40.79K | 129.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 21894 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 34332 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 73371 | 0.310 |
2 | 14324 | 0.305 |
8 | 32432 | 0.300 |
3 | 10523 | 0.295 |
11 | 90433 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 75300 | 3 |
0.320 | 523 | 1 |
0.325 | 290 | 1 |
0.330 | 93238 | 1 |
0.340 | 24538 | 1 |
Last trade - 13.46pm 18/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online